{Reference Type}: Journal Article
{Title}: Trends in and characteristics of drug overdose morbidity among pregnant and postpartum individuals in California, 2010-2018.
{Author}: Goldman-Mellor S;Jensen J;Cruz SS;Olfson M;Gemmill A;Yan Y;Margerison C;
{Journal}: Am J Epidemiol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 3
{Factor}: 5.363
{DOI}: 10.1093/aje/kwae177
{Abstract}: Fatal drug overdoses among pregnant and postpartum individuals have risen dramatically over the past 10 years. Trends in and characteristics of nonfatal drug overdoses in this population, however, remain unknown, despite the importance of this outcome for maternal and infant health. We used statewide, longitudinally-linked hospital and emergency department administrative claims data from California to characterize the incidence, trends, drug type involvement, and sociodemographic disparities in pregnancy-associated drug overdose between 2010 and 2019. Generalized linear models accounting for multiple deliveries per individual were used to test for trends; descriptive statistics were used for other study analyses. Of California individuals with a live delivery between 2010 and 2018, approximately 0.2% had a pregnancy-associated drug overdose. Nonfatal overdoses were nearly 60 times more common than fatal overdoses. Incidence of overdoses involving stimulants increased in frequency, while incidence of overdoses involving sedative/hypnotic drugs and psychotropic medications decreased in frequency. Risk of overdose was substantially higher among delivering individuals who were young, non-Hispanic Black, Medicaid patients, or who lived in non-metropolitan areas. Ongoing public health surveillance of and clinical interventions to reduce pregnancy-associated nonfatal drug overdose events are critical for prevention efforts.